Background illustration for clinical trials search

Macular Degeneration Clinical Trials

Browse 119 macular degeneration clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Prospective Study Phase: Retinal Oxygen Saturation, Blood Flow, Vascular Function and High Resolution Morphometric Imaging in the Living Human Eye

for
Age Related Macular Degeneration, Glaucoma,
Location: Toronto
Sponsor: University of Toronto

Sex: All

Age: 40 - 70+

Code: NCT01348672

Recruiting

A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)

for
Stargardt Disease, Stargardt Macular Degeneration,
Location: Boston MA, Miami FL, Dallas TX, Aurora CO, Portland OR
Sponsor: Splice Bio

Sex: All

Age: 12 - 65

Code: NCT06942572

Phase1, Phase2, Recruiting

Active AMD Study to Improve Function in Veterans

for
Age Related Macular Degeneration (AMD)
Location: Decatur GA
Sponsor: VA Office of Research and Development

Sex: All

Age: 65 - 70+

Code: NCT05932069

Recruiting

Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD

for
Age-related Macular Degeneration
Location: Boston MA
Sponsor: Massachusetts Eye and Ear Infirmary

Sex: All

Age: 50 - 70+

Code: NCT04735263

Phase2, Recruiting

Visual Remapping to Aid Reading With Field Loss

for
Age-related Macular Degeneration
Location: Minneapolis MN
Sponsor: University of Minnesota

Sex: All

Age: 16+

Code: NCT03848663

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Phase II/III Study of the Efficacy and Safety of MacuCLEAR MC-1101 in Treating DryAge-Related Macular Degeneration

for
Non-Exudative Age Related Macular Degeneration
Location: Murray UT
Sponsor: MacuCLEAR, Inc.

Sex: All

Age: 50 - 70+

Code: NCT02127463

Phase2, Phase3, Recruiting

Cytokine and Visual Outcome Variations in Eyes Receiving Ranibizumab

for
Age Related Macular Degeneration, Diabetic Macular Edema,
Location: Toronto
Sponsor: Unity Health Toronto

Sex: All

Age: 18+

Code: NCT03056092

Recruiting

Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)

for
Stargardt Disease, Cone Rod Dystrophy,
Location: Boston MA, Philadelphia PA, Miami FL, Gainesville FL,
Sponsor: Ascidian Therapeutics, Inc

Sex: All

Age: 12+

Code: NCT06467344

Phase1, Phase2, Recruiting

National Eye Institute Biorepository for Retinal Diseases

for
Age-Related Macular Degeneration, Diabetic Retinopathy,
Location: Bethesda MD
Sponsor: National Eye Institute (NEI)

Sex: All

Age: 2 - 70+

Code: NCT01496625

Recruiting

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

for
Geographic Atrophy, Macular Degeneration
Location: Portland ME, Boston MA, Norfolk VA, Baltimore MD,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 60+

Code: NCT06635148

Phase2, Phase3, Recruiting

A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT

for
Macular Degeneration, Geographic Atrophy, Stargardt Disease
Location: Dallas TX
Sponsor: Nanoscope Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT06805474

Recruiting

Telemedicine in Age-Related Macular Degeneration

for
Age Related Macular Degeneration
Location: New York NY
Sponsor: The New York Eye & Ear Infirmary

Sex: All

Age: 50+

Code: NCT04863391

Recruiting

(CIRRUS-2023-1) CLINICAL CLIN Assessment of PathFinder 1.0 on the CIRRUS 6000 and the CIRRUS 5000

for
Epiretinal Membrane, Dry Age Related Macular Degeneration,
Location: Portland ME, Fort Lauderdale FL, Kansas City MO,
Sponsor: Carl Zeiss Meditec-Dublin CoCe

Sex: All

Age: 18+

Code: NCT07680244

Recruiting

Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study

for
Neovascular Age-Related Macular Degeneration (nAMD)
Location: Waterford CT, Hagerstown MD, Fort Lauderdale FL,
Sponsor: Ocular Therapeutix, Inc.

Sex: All

Age: 50+

Code: NCT07516132

Phase3, Recruiting

Lesion-tailored, Fundus-controlled Perimetry in Geographic Atrophy (GA).

for
Geographic Atrophy From Age-related Macular Degeneration
Location: Salt Lake City UT
Sponsor: University of Utah

Sex: All

Age: 65 - 70+

Code: NCT07582042

Recruiting

A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

for
Neovascular Age-related Macular Degeneration, nAMD
Location: Boston MA, Waterford CT, Oceanside NY, Scarsdale NY,
Sponsor: Amgen

Sex: All

Age: 50+

Code: NCT07614776

Phase3, Recruiting

Phase 1 Study of C.001 in Retinal Degeneration

for
Geographic Atrophy, Stargardt Disease, RPE-mediated Maculopathy,
Location: Beverly Hills CA
Sponsor: Cellio Therapeutics Inc

Sex: All

Age: 18+

Code: NCT07594236

Phase1, Recruiting

Central micrOperimetry and Radial OCT Evaluation in Geographic Atrophy (CORE-GA): a Prospective Pilot Study

for
Age-Related Macular Degeneration, Geographic Atrophy
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 55+

Code: NCT07556406

Recruiting

High Resolution Retinal Imaging

for
Stargardts, Retinitis Pigmentosa,
Location: Philadelphia PA
Sponsor: University of Pennsylvania

Sex: All

Age: 7+

Code: NCT01866371

Recruiting

Strategies for Improving Linkage-to-Care After Eye Disease Screening

for
Age Related Macular Degeneration, Diabetic Retinopathy,
Location: San Francisco CA
Sponsor: University of California, San Francisco

Sex: All

Age: 60+

Code: NCT06943599

Recruiting